The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.
Aragón-Herrera A, Moraña-Fernández S, Otero-Santiago M, Anido-Varela L, Campos-Toimil M, García-Seara J, Román A, Seijas J, García-Caballero L, Rodríguez J, Tarazón E, Roselló-Lletí E, Portolés M, Lage R, Gualillo O, González-Juanatey JR, Feijóo-Bandín S, Lago F.
Aragón-Herrera A, et al. Among authors: campos toimil m.
Biomed Pharmacother. 2023 May;161:114535. doi: 10.1016/j.biopha.2023.114535. Epub 2023 Mar 15.
Biomed Pharmacother. 2023.
PMID: 36931025
Free article.